Fresenius | FRE - Ativo Circulante





Ativo Circulante Alterar Data
Akzo Nobel EUR 6.06B 19M 2025-12
Alcon AG USD 6.45B 116M 2025-12
AstraZeneca USD 28.72B 1.22B 2025-12
BASF EUR 31.68B 1.4B 2025-12
Bayer EUR 32.91B 30M 2025-12
Beiersdorf EUR 6.66B 8M 2025-12
DaVita Healthcare Partners USD 4.06B 53.82M 2025-12
Demant DKK 10.08B 128M 2025-12
E.ON EUR 22.28B 481M 2025-12
Essilor EUR 12.01B 981M 2025-12
Fresenius EUR 12.06B 1.18B 2025-09
Fresenius Medical Care EUR 7.9B 74M 2025-12
Getinge SEK 18.16B 1.83B 2024-12
Givaudan CHF 4.07B 258M 2025-12
GlaxoSmithKline GBP 17.51B 332M 2025-12
GN Store Nord DKK 8.64B 105M 2025-12
GRIFOLS EUR 5.07B 274.77M 2025-12
Hikma Pharmaceutical USD 2.64B 86M 2025-12
Lonza CHF 8B 3.41B 2025-12
Merck EUR 13.23B 354M 2025-12
Novartis USD 30.46B 2.26B 2025-12
Philips EUR 9.93B 654M 2025-12
Roche Holding CHF 38.73B 3.03B 2025-12
RWE EUR 34.33B 7.84B 2025-12
Sanofi EUR 30.95B 3.09B 2025-12
Smith & Nephew USD 4.63B 169M 2025-12